Cargando…

Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis

Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remove lesions, all of which provide a temporary but not complete cure. Here we identify an en...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugihara, K., Kobayashi, Y., Suzuki, A., Tamura, N., Motamedchaboki, K., Huang, C.-T., Akama, T.O., Pecotte, J., Frost, P., Bauer, C., Jimenez, J.B., Nakayama, J., Aoki, D., Fukuda, M.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109024/
https://www.ncbi.nlm.nih.gov/pubmed/25047118
http://dx.doi.org/10.1038/ncomms5478
_version_ 1782327826818531328
author Sugihara, K.
Kobayashi, Y.
Suzuki, A.
Tamura, N.
Motamedchaboki, K.
Huang, C.-T.
Akama, T.O.
Pecotte, J.
Frost, P.
Bauer, C.
Jimenez, J.B.
Nakayama, J.
Aoki, D.
Fukuda, M.N.
author_facet Sugihara, K.
Kobayashi, Y.
Suzuki, A.
Tamura, N.
Motamedchaboki, K.
Huang, C.-T.
Akama, T.O.
Pecotte, J.
Frost, P.
Bauer, C.
Jimenez, J.B.
Nakayama, J.
Aoki, D.
Fukuda, M.N.
author_sort Sugihara, K.
collection PubMed
description Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remove lesions, all of which provide a temporary but not complete cure. Here we identify an endometriosis-targeting peptide that is internalized by cells, designated z13, using phage display. As most endometriosis occurs on organ surfaces facing the peritoneum, we subtracted a phage display library with female mouse peritoneum tissue and selected phage clones by binding to human endometrial epithelial cells. Proteomics analysis revealed the z13 receptor as the cyclic nucleotide-gated channel β3, a sorting pathway protein. We then linked z13 with an apoptosis-inducing peptide and with an endosome-escaping peptide. When these peptides were co-administered into the peritoneum of baboons with endometriosis, cells in lesions selectively underwent apoptosis with no effect on neighbouring organs. Thus, this study presents a strategy that could be useful to treat peritoneal endometriosis in humans.
format Online
Article
Text
id pubmed-4109024
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-41090242014-08-15 Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis Sugihara, K. Kobayashi, Y. Suzuki, A. Tamura, N. Motamedchaboki, K. Huang, C.-T. Akama, T.O. Pecotte, J. Frost, P. Bauer, C. Jimenez, J.B. Nakayama, J. Aoki, D. Fukuda, M.N. Nat Commun Article Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remove lesions, all of which provide a temporary but not complete cure. Here we identify an endometriosis-targeting peptide that is internalized by cells, designated z13, using phage display. As most endometriosis occurs on organ surfaces facing the peritoneum, we subtracted a phage display library with female mouse peritoneum tissue and selected phage clones by binding to human endometrial epithelial cells. Proteomics analysis revealed the z13 receptor as the cyclic nucleotide-gated channel β3, a sorting pathway protein. We then linked z13 with an apoptosis-inducing peptide and with an endosome-escaping peptide. When these peptides were co-administered into the peritoneum of baboons with endometriosis, cells in lesions selectively underwent apoptosis with no effect on neighbouring organs. Thus, this study presents a strategy that could be useful to treat peritoneal endometriosis in humans. Nature Pub. Group 2014-07-22 /pmc/articles/PMC4109024/ /pubmed/25047118 http://dx.doi.org/10.1038/ncomms5478 Text en Copyright © 2014, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Sugihara, K.
Kobayashi, Y.
Suzuki, A.
Tamura, N.
Motamedchaboki, K.
Huang, C.-T.
Akama, T.O.
Pecotte, J.
Frost, P.
Bauer, C.
Jimenez, J.B.
Nakayama, J.
Aoki, D.
Fukuda, M.N.
Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
title Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
title_full Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
title_fullStr Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
title_full_unstemmed Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
title_short Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
title_sort development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109024/
https://www.ncbi.nlm.nih.gov/pubmed/25047118
http://dx.doi.org/10.1038/ncomms5478
work_keys_str_mv AT sugiharak developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT kobayashiy developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT suzukia developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT tamuran developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT motamedchabokik developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT huangct developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT akamato developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT pecottej developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT frostp developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT bauerc developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT jimenezjb developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT nakayamaj developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT aokid developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis
AT fukudamn developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis